What is the best resolution for cataracts
The discovery of N-acetylcarnosine, within the form of Can-C eye drops for the therapy and reversal of canine cataract has provided a safe and effective alternative to costly and dangerous eye surgery. Confirmed in clinical trials and in use now for over 10 years by pet owners and veterinarians across the globe, Can-C has proven itself to be the optimal therapy for canines suffering from debilitating cataracts.
N-acetylcarnosine is a special ocular type of the peptide, L-carnosine a natural antioxidant that can reverse and prevent the effects of age-related problems like cataract. Canine cataract can cause varying degrees of incapacity in canine which can range from barely blurry vision to a complete loss of vision or blindness. In canines, cataracts are sometimes hereditary and gradual of their development, blocking more and more vision as the animal matures into previous age.
Under the supervision of Innovative Vision Products founder, Dr. Mark Babizhayev MA PhD, clinical research had been performed on rabbits, canines and ultimately on people to check the efficacy and security of Can-C N-acetylcarnosine eye drops. The study produced remarkable outcomes with no unfavourable aspect effects noted and the beneficial affects proved to be sustainable. The trials resulted in an astounding 96% enchancment of affected canine eyes. Improved visual behaviour of the participants was famous within a number of weeks of treatment. Canine with either immature or ripe cataracts confirmed significant decrease of cataract symptoms. Reversal of the disease condition started from the periphery of the affected lens with increased transparency of the entire lens over the interval of the trial. Interestingly it was famous that canine cataracts actually responded earlier to the remedy then their human counterparts.
